Evaluation of RevA, a fibronectin-binding protein of Borrelia burgdorferi, as a potential vaccine candidate for lyme disease. [electronic resource]
- Clinical and vaccine immunology : CVI Jun 2013
- 892-9 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural